HomeTagsAstellas

Astellas

Biotechnology

Astellas and Pantherna Enter into a New Technology Evaluation Agreement

PR Newswire - October 4, 2022

Astellas Pharma Inc. and Pantherna Therapeutics GmbH announced that the companies have entered into a new technology evaluation agreement for research to generate mRNA-based...

Biotechnology

Astellas Unveils Plans to Open New Biotech Campus in South San Francisco

PR Newswire - July 24, 2022

Astellas Pharma Inc. announced plans to create an integrated biotechnology campus in South San Francisco as its West Coast innovation and research center. The...

Biotechnology

Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults

PR Newswire - June 27, 2022

Astellas Pharma Inc. announced that the US Food and Drug Administration (FDA) has placed a clinical hold on the FORTIS Phase 1/2 trial following...

Biotechnology

Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology

PR Newswire - June 1, 2022

Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and GO Therapeutics, Inc. (Co-Founder and CEO: Constantine Theodoropulos, "GO") announced that Xyphos Biosciences,...

Biotechnology

Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement

PR Newswire - February 1, 2022

Exopharm Limited has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM). Also Read: Novavax and Israel Announce Advance...